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Segmental progeroid syndromes are groups of disorders with multiple features suggestive
of accelerated aging. One subset of adult-onset progeroid syndromes, referred to as
atypical Werner syndrome, is caused by mutations in the LMNA gene, which encodes a
class of nuclear intermediate ﬁlaments, lamin A/C.We previously described rapid telomere
attrition and accelerated replicative senescence in cultured ﬁbroblasts overexpressing
mutant lamin A. In this study, we investigated the cellular phenotypes associated with
accelerated telomere shortening in LMNA mutant primary ﬁbroblasts. In early passage
primary ﬁbroblasts with R133L or L140R LMNA mutations, shelterin protein components
were already reduced while cells still retained telomere lengths comparable to those of
controls. There was a signiﬁcant inverse correlation between the degree of abnormal
nuclear morphology and the level ofTRF2, a shelterin subunit, suggesting a potential causal
relationship. Stabilization of the telomeres via the introduction of the catalytic subunit
of human telomerase, hTERT (human telomerase reverse transcriptase), did not prevent
degradation of shelterin components, indicating that reduced TRF2 in LMNA mutants is
not mediated by short telomeres. Interestingly, γ-H2AX foci (reﬂecting double strand DNA
damage) in early passage LMNA mutant primary ﬁbroblasts and LMNA mutant hTERT
ﬁbroblasts were markedly increased in non-telomeric regions of DNA. Our results raise the
possibility that mutant lamin A/C causes global genomic instability with accumulation of
non-telomeric DNA damage as an early event, followed byTRF2 degradation and telomere
shortening.
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INTRODUCTION
Segmental progeroid syndromes are a genetically heterogeneous
collection of disorders whose presentations resemble accelerated
aging (Martin, 1978). The best known example of an adult-onset
segmental progeroid syndrome is theWerner syndrome (“Progeria
of Adult”; WS), caused by mutations in the WRN gene (Yu et al.,
1996; Friedrich et al., 2010). Our International Registry of Werner
syndrome (www.wernersyndrome.org/registry/registry) has accu-
mulated several dozen cases of “atypical” WS (AWS) – cases
submitted by clinicians to us as examples of WS, but lack WRN
mutations and have normal levels of the WRN protein. A small
subset of AWS cases are caused by LMNA mutations (Chen et al.,
2003). The LMNA gene encodes nuclear intermediate ﬁlaments,
laminA and laminC, themajor components of the nuclear lamina.
These provide the nucleus with mechanical support and con-
tribute to functional interactions with chromatin (Broers et al.,
2006; Andres and Gonzalez, 2009). R133L and L140R are het-
erozygous dominant LMNA mutations located at the surface of
a heptad repeat, suggesting that these mutations might perturb
the intermolecular interactions of lamin A/C (Chen et al., 2003).
There have been additional reports of heterozygous dominant
LMNA mutations in AWS cases, including our recent report of
heterozygous substitutions at the junction of LMNA exon 11 and
intron 11, which results in the generation of a very small amount
of progerin (Hisama et al., 2011). Progerin is an aberrant splice
form of lamin A; high levels are responsible for Hutchinson–
Gilford progeria syndrome (“Progeria of Childhood”; HGPS; De
Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). In addition
to progeroid syndromes, LMNAmutations are also responsible for
muscular dystrophies, cardiomyopathies, partial lipodystrophies,
and peripheral neuropathies (Broers et al., 2006).
Cells carrying LMNAmutations exhibit characteristicmorpho-
logical nuclear abnormalities and alteredmechanical properties of
the lamina (Dahl et al., 2006). In addition to its structural roles,
the nuclear lamina interacts with chromatin to participate in chro-
matin remodeling and heterochromatin organization, providing
maintenance of nuclear organization, (Broers et al., 2006; Andres
and Gonzalez, 2009), and thus inﬂuencing replication timing and
transcription (Gonzalez-Suarez and Gonzalo, 2010; Hansen et al.,
2010). In HGPS ﬁbroblasts, changes in the lamina structure result
in reorganization of heterochromatin and epigenetic changes in
histones (Shumaker et al., 2006).
Cellular characteristics of human ﬁbroblasts expressing
progerin include genome instability such as increased γ-H2AX
foci, continuous p53 activation (Liu et al., 2005; Scafﬁdi and
Misteli, 2006; Kudlow et al., 2008; Musich and Zou, 2011), and
defective cell proliferation, which can be partially overcome
by inactivation of p53, ATM (ataxia telangiectasia mutated),
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and ATR (ATM- and RAD3-related) or introduction of human
telomerase reverse transcriptase (hTERT; Liu et al., 2006; Kudlow
et al., 2008). Furthermore, several studies have shown a role for
A-type lamins in telomere maintenance (Gonzalez-Suarez et al.,
2009; Benson et al., 2010). In primary ﬁbroblasts derived from
HGPS patients, DNA damage foci were shown to be localized
to the telomeres in association with accelerated replicative senes-
cence (Benson et al., 2010). hTERT immortalization of HGPS
ﬁbroblasts has been shown to lead to a reduction of p53 path-
way signaling, further supporting the idea that the telomere
may be a major DNA target of progerin (Benson et al., 2010).
However, in an independent study, hTERT failed to prevent
the accumulation of DNA damage upon induction of exoge-
nous progerin expression (Scafﬁdi and Misteli, 2008). Studies of
LMNA knockout mice provided evidence that lamin A/C inter-
acts with telomeres and maintains the distribution of telomeres
throughout the nucleus (Gonzalez-Suarez et al., 2009). Altered
distributions of telomeres in LMNA knockout mouse cells were
associated with deprotection and hyper-recombination of telom-
eric DNA, resulting in accelerated telomere loss and a DNA
damage response (Gonzalez-Suarez et al., 2009). This suggests that,
depending on the nature of the LMNA mutation(s), altered lamin
A/C may lead to accelerated telomere shortening via different
mechanisms.
We previously demonstrated that human ﬁbroblasts which
over-express either the wild type lamin A, the mutant lamin A
found in HGPS patients (delta 35 and delta 50), or the lamin
A mutations in AWS patients (R133L and L140R), all undergo
accelerated telomere attrition and rapid replicative senescence
(Huang et al., 2008). Unlike the classical deletions that cause
HGPS, amino acid substitutions of lamin A/C, such as those
found in patients with AWS, have not been well studied for their
effects on telomeres. It has been well established that telom-
eres become dysfunctional through replicative telomere attrition,
inhibition of shelterin or the activation of oncogenes (Denchi
and de Lange, 2007; Sfeir and de Lange, 2012; Suram et al.,
2012). In this study, we investigated the cellular phenotypes
associated with accelerated telomere shortening in AWS ﬁbrob-
lasts focusing on the shelterin complex. The shelterin complex
protects chromosomal ends from erosions and consists of six
major proteins, TRF2, TRF1, POT1, TPP1, Rap1, and TIN2
(Palm and de Lange, 2008). The POT1–TPP1 complex com-
petes with the CST (CTC1, STN1, and TEN1) complex which
terminates telomerase activity (Chen et al., 2012). Among shel-
terin components, TRF2 in particular is thought to play an
important role in the protection of telomeres from erosion by
binding to telomeric repeats to form a t-loop (Palm and de
Lange, 2008). Loss of TRF2 protein expression or activity was
found to trigger telomere shortening, the DNA damage response,
chromosomal instability, and replicative senescence (Oh et al.,
2003; Denchi and de Lange, 2007; Okamoto et al., 2013). TRF2
was shown to co-precipitate with lamin A (Luderus et al., 1996)
and also to interact with lamin-associated proteins, LAP-2α and
BAF, in a cell cycle dependent manner (Dechat et al., 2004).
In the present study we observed signiﬁcantly reduced levels
of TRF2 and other shelterin proteins in LMNA mutant AWS
cells. We suggest that this reduction in protein levels is due
to the degradation of TRF2 protein. Using immuno-ﬂuorescent
in situ hybridization (immuno-FISH) analysis we found that
LMNA mutant cells accumulate increased levels of non-telomeric
DNA damage in LMNA mutant hTERT cells. We therefore sug-
gest that these forms of mutant lamin A induce genomic DNA
damage and that such damage may contribute to the reduction
of TRF2 proteins via activation of the p53-mediated signaling
cascades, leading to the degradation of shelterin proteins. Sub-
optimum shelterin-telomere interactions may further lead to a




Patients signed approved consent forms to participate in the stud-
ies of the International Registry ofWerner Syndrome (Seattle,WA,
USA) prior to the initiation of the study. This study was approved
by the Human Subjects Division, Institutional Review Board of
the University of Washington, Seattle,WA, USA.
CELL LINES AND CELL CULTURE
Human diploid ﬁbroblast cell lines were established from biopsies
of skin samples. Cell lines 82-6 and 88-1 (normal) were obtained
from newborn foreskin and the abdominal skin of a 62 year
old female, respectively. Fibroblasts were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA,
USA) supplementedwith 10%heat-inactivated fetal bovine serum
(FBS; Thermo Scientiﬁc Hyclone, OH, USA) and penicillin and
streptomycin (Invitrogen), as previously described (Chen et al.,
2003). The media was changed every 3–4 days. All cells were cul-
tured at 37◦C in 5% CO2. Primary ﬁbroblasts were immortalized
with a construct encoding hTERT (Rubio et al., 2002). MG-132
(10 μM, Calbiochem, La Jolla, CA, USA) and cycloheximide
(100 μg/ml, Sigma, St. Louis, MO, USA) was used when treating
ﬁbroblasts.
BrdU INCORPORATION ASSAY
To determine the fraction of proliferating cells, a 5-bromo-2′-
deoxyuridine (BrdU) incorporation assay was carried out using a
BrdU labeling and detection kit (11 296 736 001, Roche Applied
Science, Indianapolis, IN, USA) according to the manufacturer’s
instructions. Brieﬂy, primary ﬁbroblasts from control, LMNA
mutant and WRN mutant cell lines were grown for 24 h on cover
slips. Cells were then labeled with BrdU (10 μM) for 24 or 48 h,
ﬁxed in 70% ethanol with 50 mM glycine for 20 min at −20◦C
and processed for immunoﬂuorescence. Cells were then incubated
with the primary antibody, anti-BrdU (mouse monoclonal anti-
body, clone BMG 6H8 IgG1, 1:10 dilution) for 30 min at 37◦C
followed by Alexa Fluor 594-conjugated goat anti-mouse anti-
body (1:200 dilution; A-11005, Molecular Probes, Eugene, OR,
USA) for 30 min at 37◦C. Cells were mounted onto slides using
Vectashield with DAPI (Vectashield, Burlingame, CA, USA) and
observed and photographed with Nikon Upright (Nikon Eclipse
E600) microscope at the Keck Center for Imaging, University of
Washington, Seattle,WA,USA.Thepercentages of cellswithBrdU-
labeled nuclei were determined by counting 300 cells per data
point.
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WESTERN BLOT ANALYSIS
For western blot analyses, cells were lysed in 2× Laemmli
buffer [0.5 M Tris pH 6.8, 10% sodium dodecyl sulfate (SDS)
glycerol]. Fifteen micrograms of total protein isolated from
primary ﬁbroblasts or immortalized ﬁbroblast cell lines were sep-
arated on NuPAGE 4–12% gradient Bis–Tris gel (Invitrogen) and
transferred to polyvinylidene ﬂuoride (PVDF) membranes. The
membranes were incubated with anti-TRF2 (IMG-124A, clone
4a794.15, Imgenex, San Diego, CA, USA and sc-32106, Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA), anti-TRF1 (sc-
5596, Santa Cruz Biotechnology Inc), anti-POT1 (sc-27952, Santa
Cruz Biotechnology Inc.), anti-TIN2 (IMG-282, clone 59B388.1,
Imgenex), anti-hRap1 (IMG-289, Imgenex), anti-TPP1 (ab54685,
Abcam Inc., Cambridge,MA,USA) at a dilution of 1:2000 or anti-
β-actin (clone AC-15, Sigma, St Louis, MO, USA) at a dilution
of 1:40,000 in a milk blocking solution, then with correspond-
ing biotinylated secondary antibodies against mouse, rabbit or
goat IgG (Vector Laboratories, Burlingame, CA, USA). The reac-
tions were visualized with western lightening chemiluminescence
reagent (NEL100, Perkin Elmer, Waltham, MA, USA) according
to the manufacturer’s instruction. The bands corresponding to
TRF2, TRF1, POT1, TIN2, hRap1, andTPP1were quantiﬁed using
TotalLab software (Newcastle, UK) and normalized againstβ-actin
levels.
For the measurement of the TRF2 protein half-life, immortal-
ized ﬁbroblast cell lines from the control, LMNAmutant andWRN
mutant were treated with cycloheximide (100 μg/ml) for 8–12 h.
Total protein extracts were subjected to the western analysis of
TRF2 and β-actin as described above. After normalizing to β-actin
levels, TRF2 levels were calculated in order to estimate the protein
half-lives.
QUANTITATIVE REAL TIME PCR
Quantitative reverse transcription polymerase chain reaction (RT-
PCR) for TRF2 mRNAwas performed using Taqman gene expres-
sion assay system (Hs00194619_m1, Applied Biosystem, Foster
City, CA, USA) and normalized against mRNA level of GAPDH
(Hs02758991_g1, Applied Biosystem). Total RNA was isolated
from the cultured cell pellet using Qiagen RNA isolation kit (Qia-
gen,Valencia,CA,USA) following themanufacturer’s instructions.
Reverse transcriptionwas carried outwith 2μg isolated total RNA.
Quantitative PCR was performed with a Rotor-Gene 3000 (Cor-
bett Research, Sydney,Australia). The data analysis was performed
as previously described (Huang et al., 2008).
TELOMERE QUANTITATIVE POLYMERASE CHAIN REACTION
Mean telomere lengths were determined by qPCR as previously
described (Huang et al., 2008). Genomic DNA was isolated via
a salting out method and qPCR was performed with a Rotor-
Gene 3000 (Corbett Research, Sydney, Australia). The data were
analyzed as previously described (Huang et al., 2008). The intra-
assay and inter-assay variability (CV) for qPCR was 3 and 5%,
respectively.
TELOMERASE REPEAT AMPLIFICATION PROTOCOL ASSAY
Telomerase activity in hTERT-immortalized cell lines was
measured using the TRAPEZE XL Telomerase detection kit
(S7707, Millepore, Billerica, MA, USA). Cells were lysed in
ice-cold 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate (CHAPS) lysis buffer for 30 min. 2 μl of the cell extract
was analyzed for the telomerase repeat ampliﬁcation protocol
(TRAP) assay. In the ﬁrst step telomeric repeats were added to a
substrate oligonucleotide by telomerase; then, the extended prod-
ucts were ampliﬁed by Taq polymerase using PCR with TS and
RP (reverse) primers, generating a ladder of products in 6 base
increments. The PCR products were separated on a 10% non-
denaturing polyacrylamide gel (PAGE). The gel was stained with
SYBR Safe (S33102, Invitrogen) to visualize the TRAP ladder using
FluorChem Q imaging system (Alpha Innotech, San Leandro, CA,
USA).
IMMUNO-FISH
Immuno-ﬂuorescent in situ hybridization was performed as
described previously (O’Sullivan et al., 2004) with modiﬁcations.
Cells were grown on coverslips overnight and then ﬁxed the next
day with 3.7% paraformaldehyde in phosphate buffered saline
(PBS; pH 7.4) plus 0.2% Triton X100 for 10 min at room temper-
ature. Cells were blocked for 30 min at 37◦C and incubated with
primary antibody, mouse anti-TRF2 (IMG-124A, clone 4a794.15,
Imgenex) or rabbit anti-γ-H2AX (2577, Cell Signaling Technolo-
gies, Beverly, MA, USA) for 30 min at 37◦C. They were then
incubated with secondary antibody, donkey anti-mouse Alexa
Fluor or donkey anti-rabbit Alexa Fluor (Invitrogen Molecular
Probes, Eugene, OR, USA) for 1 h at room temperature, and then
post-ﬁxed with 3.7% paraformaldehyde for 5 min. After wash-
ing in PBS, cells were processed for FISH. Cells were treated with
100 μg/ml of RNase A (Sigma-Aldrich, St. Louise, MO, USA) in
PBS for 45 min. at 37◦C, then dehydrated in an ethanol series
and air dried. Peptide nucleic acid (PNA) probe (200 nM, Cent-
FAM, TelC-FITC, or TelC-Cy3; Panagene Inc., Daejeon, Korea) in
hybridization buffer was placed on top of the coverslips, heated to
75–78◦C for 15 min, then removed, wrapped in foil and allowed
to sit at room temperature overnight. The next day the cover-
slips were washed with 70% formamide in Tris buffer, washed
with preheated (55–60◦C) Tween 20 solution, dehydrated in
an ethanol series and then air dried. Coverslips were mounted
on slides with DAPI (Vectashield) and sealed with clear nail
polish.
IMAGE PROCESSING AND ANALYSIS OF TELOMERE LENGTH, TRF2
INTENSITIES AND CO-LOCALIZATION
The images were obtained in Z-series with Deltavision deconvo-
lution microscope (Applied Precision, Issaquah, WA, USA) at the
Keck Center (University of Washington, Seattle, WA, USA). The
images were deconvolved using SoftWorx software (Applied Preci-
sion, Issaquah,WA,USA).Theywere analyzed for average telomere
intensity (which is proportional to telomere length), and aver-
age TRF2 intensity using a software program, 4xColocalization,
version 138, provided by the University of Washington Nathan
Shock Center, as described previously (O’Sullivan et al., 2004).
The images were also analyzed for co-localization (telomere and
TRF2; telomere and γ-H2AX; TRF2 and γ-H2AX). Statistical sig-
niﬁcance was determined by the Student t-test (Chen et al., 2003;
Huang et al., 2008).
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NUCLEAR MORPHOLOGY AND CORRELATION ANALYSIS
To assess the degree of nuclear irregularity, nuclear contour ratios
(NCRs) were determined in randomly selected nuclei of LMNA
mutant ﬁbroblasts using MetaMorph software as described previ-
ously (Saha et al., 2010). The nuclei were also analyzed for average
TRF2 intensities. The correlation between NCR and TRF2 inten-
sities was analyzed using Pearson’s correlation coefﬁcient, r. For
all experiments, a two-tailed P value of <0.05 was considered
signiﬁcant.
RESULTS
REDUCTION OF SHELTERIN COMPONENTS IN PRIMARY LMNA
MUTANT FIBROBLASTS
We ﬁrst analyzed the steady state protein expression levels of the
shelterin subunits TRF2, TRF1, POT1, TIN2, TPP1, and Rap1
in primary ﬁbroblasts carrying a heterozygous R133L mutation
derived from Registry# PORTU8010 and in primary ﬁbroblasts
carrying a heterozygous L140R mutation derived from Registry#
NORWAY1010 (Chen et al., 2003). The controls were two normal
primary ﬁbroblast cultures, 82-6 and 88-1 (Oshima et al., 1995;
Huang et al., 2008) as well as cultures of WRN mutant ﬁbroblasts,
Registry# MCI7885, derived from a patient with classical Werner
syndrome (Oshima et al., 1995; Yu et al., 1996). The latter was
included as a “control” since these ﬁbroblasts undergo accelerated
telomere shortening by different mechanisms, namely defects in
lagging strand synthesis of telomeres (Crabbe et al., 2004). We
examined ﬁbroblasts in early passages (BrdU labeling index higher
than 60%) in order to detect proximal changes rather than changes
secondary to telomere shortening and replicative senescence.
Western analysis showed that most subunits of the shelterin
complex were reduced in both types of LMNA mutant ﬁbroblasts
(Figure 1A). Steady state levels of TRF2 were 46 and 45%, POT1
was 57 and 56%, TIN2 was 36 and 35%, and Rap1 was 46 and
40%, in R133L and L140R mutants, respectively, compared to
the control, 82-6 ﬁbroblasts (Figure 1B). The other two compo-
nents, TRF1 and TPP1, were also slightly reduced to 73 and 62% in
R133Lmutants and 74 and 92% inL140Rmutants (Table 1). Inter-
estingly, WRN mutant ﬁbroblasts also showed reduced protein
expression of all of the shelterin components.
Since the length of the telomere determines the number of
available binding sites for the shelterin complex, cells with short
telomeres (i.e., late passage or senescent cells) would require and
presumably express lower amounts of the shelterin components.
To rule out this possibility, relative telomere lengthsweremeasured
by quantitation of ﬂuorescence in situ hybridization images (Q-
FISH), as established for normal ﬁbroblasts undergoing replicative
senescence (O’Sullivan et al., 2004). Using this method, we found
that the telomere lengths of young LMNA mutant ﬁbroblast cul-
tures were comparable to those of controls after normalizing to
centromere signal intensities (Figure 1C). Mean telomere lengths
were also measured by quantitative PCR, showing no signiﬁ-
cant differences among LMNA mutant ﬁbroblasts and controls
(Figure 1C). The mean telomere lengths of the two controls were
similar despite the difference in the age of donors, 82-6 (new-
born) and 88-1 (adult; Figure 1C). This may be due to the fact
that there is a wide range of mean telomere lengths and replica-
tive life spans among normal individuals. The labeling index
determined by the 48 h BrdU incorporation and population dou-
bling (PD) of the culture were 94% in 82-6 (PD 9), 89% in 88-1
(PD 7), 71% in R133L (PD 5), 96% in L140R (PD 6), and 91%
in MCI7885 (PD 6), conﬁrming that the LMNA mutant ﬁbrob-
last cultures used in these experiments were indeed from young
passages. This indicates that the reduction of shelterin proteins
observed in LMNA mutants was not a direct result of shortened
telomeres.
Next, we focused on the role of TRF2, a major component
of the shelterin complex, in preventing telomere erosion. To
determine whether the reduction of TRF2 proteins in LMNA
mutant ﬁbroblasts occurs via a transcriptionalmechanismor post-
transcriptional degradation, we analyzed TRF2 expression at the
mRNA level. The qRT-PCR results showed that the steady state
levels of TRF2 mRNA in LMNA mutant ﬁbroblasts were not sig-
niﬁcantly different when compared to the controls (Figure 1D).
These results suggest that the TRF2 protein may undergo degra-
dation in LMNA mutant cells, resulting in low TRF2 protein levels
while the cells still retain long telomeres.
NUCLEAR MORPHOLOGICAL ABNORMALITIES CORRELATE WITH
REDUCTIONS OF TRF2 WITHIN LMNA MUTANT CULTURES
We previously reported that primary LMNA mutant ﬁbrob-
lasts, but not control ﬁbroblasts or immortalized LMNA mutant
cells, exhibit abnormal nuclear morphology, as assessed by NCR
(Chen et al., 2003). In control ﬁbroblasts, 82-6, the contour ratio
was 0.842 ± 0.036, whereas in R133L the contour ratio was
0.749 ± 0.118 (P < 0.005); for L140R, the ratio was 0.815 ± 0.074
(P < 0.05). We noted that within the LMNA mutant cultures,
the cells with more distorted nuclei tended to have lower levels of
TRF2 (Figure 2A). Quantitative analysis revealed a signiﬁcant pos-
itive correlation between NCR and TRF2 protein level per nucleus
in both R133L and L140R mutant cultures: Pearson’s correlation
coefﬁcient, r, was 0.365 for R133L (P < 0.005) and was 0.379 for
L140R (P < 0.05; Table 2). The presence of a correlation between
and NCR and TRF2 levels supports the idea that abnormal lamin
A/C function, as reﬂected by abnormal nuclear morphology, may
be causally related to the TRF2 degradation. As expected, control
ﬁbroblast cultures did not show signiﬁcantly abnormal NCRs.
INTRANUCLEAR LOCALIZATION OF TRF2 PROTEIN IN LMNA MUTANT
CELLS
Next, we assessed the intranuclear localization of TRF2 in rela-
tion to telomeres using immuno-FISH. Co-localization analysis of
TRF2 and telomeres revealed that the fraction of signals of telom-
eric foci that overlapped with signals of TRF2 foci was slightly
less in LMNA mutant ﬁbroblasts 66% in R133L and −68% in
L140R as compared to 78% in the control, 82-6 (Figures 2B,C).
Approximately 34% (P = 0.06) of telomeric foci in the R133L
mutant and 32% (P = 0.174) in the L140R mutant were free of
TRF2. These results agree with our western results, which showed
a reduction of TRF2 protein in mass cultures. The TRF2 proteins
in LMNA mutants, albeit reduced in amount, were co-localized
to the telomeres (Figure 2B). These ﬁndings are consistent with
the hypothesis that LMNA mutant ﬁbroblasts in young passages
might have lost optimum levels of shelterin complexes prior to
telomere shortening, and that the reduced levels of TRF2 protein
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FIGURE 1 | Expression of shelterin subunits in LMNA mutant primary
fibroblasts. (A)Western analysis of TRF2, TRF1, POT1, TIN2, hRap1, and
TPP1 in control, LMNA andWRN mutant primary ﬁbroblasts. Protein levels
were normalized to β-Actin. Autoradiographies with exposures beyond the
linear range are shown for clariﬁcation of bands. (B) Densitometric scanning
of band intensities obtained from western analysis. Data are means ± s.d.
from three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
(C) Analysis of relative telomere lengths expressed as average telomere
intensities ± s.d. in indicated cell types of control, LMNA mutant andWRN
mutant ﬁbroblasts. The signal intensities were analyzed by Q-FISH using a
telomere-speciﬁc peptide nucleic acid (PNA) probe. A centromere PNA probe
was used as an internal standard. Approximately 70 cells were analyzed for
each cell line. The relative mean telomere lengths (±s.d.) in ﬁbroblasts were
measured by quantitative PCR. (D)TRF2 mRNA expression in normal, LMNA
mutant andWRN mutant ﬁbroblasts.TRF2 mRNA expression was detected
by qRT-PCR. GAPDH mRNA expression was used as an internal standard.
Data are presented as mean ± s.d. from three independent experiments.
Control (82-6) values were taken as onefold.
observed in LMNA mutants could be a causal step rather than a
consequence of accelerated telomere attrition.
R133L AND L140R MUTATIONS INDUCE ACCUMULATION OF GENOMIC
DNA DAMAGE
It has been reported that progerin induces a DNA damage
response at the telomeres (Benson et al., 2010). We asked whether
non-progerin producing LMNA mutations, R133L and L140R,
also cause the accumulation of DNA damage and if so, where. To
answer these questions, we assayed a marker of DNA damage, γ-
H2AX foci. In control ﬁbroblasts, up to approximately 4% of cells
were positive for >5 γ-H2AX foci (Figures 3A,B). The fraction
of cells with >5 γ-H2AX foci was increased to 22% (P = 0.06) in
R133L and 36% (P = 0.01) in L140R mutants (Figure 3B).
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Table 1 | Mean values of relative protein levels of shelterin
components in primary and hTERT-immortalized fibroblasts of LMNA
mutant cell lines. Protein levels in mutant lines were normalized to
the average in controls, 82-6 and 82-6 hTERT.
Shelterin
components
LMNA mutant cell lines
PORTU8010 NORWAY1010
R133L R133L hTERT L140R L140R hTERT
TRF2 0.462 0.544 0.453 0.370
TRF1 0.726 0.429 0.736 0.362
POT1 0.574 0.491 0.562 0.470
TIN2 0.363 0.785 0.345 0.590
hRap1 0.460 0.590 0.398 0.312
TPP1 0.623 1.319 0.921 1.212
To assess the degree to which the DNA damage foci in young
passages of LMNA mutant cells were localized to the telomeres,
we analyzed the co-localization of γ-H2AX and telomeres using
immuno-FISH (Figures 3A,C). In control cells, γ-H2AX sig-
nals were hardly visible as foci at standard exposures whereas
in LMNA mutant cells γ-H2AX foci tended to be larger than
those seen in the controls (Figure 3A). The majority of the γ-
H2AX foci present in LMNA mutant cells were not co-localized
to telomeric DNA (89% in RI33L and 87% in L140R; Figure 3C).
Telomeric γ-H2AX represented relatively minor fractions of the
total foci. These data indicate that, during early passages, R133L
and L140R LMNA mutant ﬁbroblasts may sustain non-telomeric
genomic damage prior to the accumulation of damage at the
telomeres.
TELOMERE STABILIZATION DOES NOT PREVENT REDUCTION OF
SHELTERIN EXPRESSION IN LMNA MUTANTS
To further conﬁrm that the reduction of shelterin complex pro-
teins and the accumulation of DNA damage seen in primary
LMNA mutant ﬁbroblasts was not due to shortened telomeres, we
analyzed TRF2 and other shelterin protein expressions in LMNA
mutant and control ﬁbroblasts immortalized with hTERT. Telom-
erase activity in all hTERT-immortalized cell lines was conﬁrmed
with a TRAP assay (data not shown). Western analysis showed
an overall reduction of most of the shelterin subunit proteins in
mutant hTERT lines in a pattern similar to what was observed
in primary ﬁbroblasts; TRF2, TRF1, POT1, TIN2, and Rap1
were reduced to 54, 43, 49, 79, and 59%, respectively, in R133L
mutant and 37, 36, 47, 59, and 31%, respectively, in L140Rmutant
hTERT ﬁbroblasts cell lines, as compared to control hTERT lines
(Figure 4A; Table 1). Both Q-FISH analysis and quantitative PCR
of the telomeres showed that the telomeres in LMNA mutant
hTERT cells were not shorter than those of control hTERT lines
(Figure 4B). These data indicate that the reduction of the shelterin
complex subunits occurs without shortened telomeres in LMNA
mutant hTERT lines, consistent with our ﬁndings in primary
ﬁbroblasts described above.
As observed in primary ﬁbroblasts, TRF2 mRNA levels in the
LMNA mutant hTERT lines were comparable to those of con-
trol hTERT lines, indicating that the reduction of TRF2 occurs
post-transcriptionally (Figure 4C). In normal human diploid
ﬁbroblasts TRF2 undergoes rapid proteasome-mediated degra-
dation after dissociation from the telomeres during replicative
senescence (Zhou et al., 2009; Fujita et al., 2010). When protea-
some degradation was inhibited by MG-132, TRF2 protein levels
in R133L and L140R mutants were partially restored from 49 to
67% and 33 to 63%, respectively (Figure 4D). This suggests that
a part of the post-translational degradation of TRF2 in LMNA
mutants is through proteasomal degradation. These data indicate
that the stabilization of telomeres by hTERT does not prevent the
degradation of TRF2 and that theremay be othermechanisms that
initiate TRF2 reduction in LMNA mutant ﬁbroblasts.
LMNA MUTANT hTERT FIBROBLASTS ACCUMULATE NON-TELOMERIC
GENOMIC DAMAGES
To examine whether DNA damage is involved in the reduction of
TRF2 in LMNA mutant cells with stable telomeres, we analyzed
DNA damage foci in hTERT-immortalized LMNA mutant and
control ﬁbroblasts. The results showed that the fraction of cells
positive for >5 γ-H2AX foci in LMNA mutant hTERT ﬁbroblasts
was decreased compared to the LMNA mutant primary ﬁbrob-
lasts. However, the number remained higher (9 and 14% in R133L
and L140R mutants, respectively) when compared to the control
hTERT cell lines, which were devoid of cells with >5 γ-H2AX foci
(Figure 5A). Co-localization analysis revealed that only 12 and 5%
of total γ-H2AX foci co-localized with TRF2 (a marker of telom-
eres) in R133L and L140R mutant cells, respectively, whereas the
rest of the DNA damage signals were distributed to non-telomeric
DNA (Figure 5B). These results indicate that mutant lamin A/C
causes the accumulation of non-telomeric DNA damage and
the reduction of TRF2 in hTERT-immortalized ﬁbroblasts with-
out substantial telomeric damage, as observed in young primary
ﬁbroblasts.
DISCUSSION
In this study we investigated the role of mutant lamin A in acceler-
ating telomere shortening using LMNAmutant ﬁbroblasts derived
from AWS patients. We observed that the levels of TRF2, along
with most of the other subunits of the shelterin complex, were
signiﬁcantly decreased in LMNA mutant ﬁbroblast cells. TRF2
mRNA levels remained unchanged as compared to control cells
with matched BrdU labeling indices. It should be emphasized that
both mutant and control primary cells used in these experiments
were in early passages, as evidenced by the labeling indices and the
comparable lengths of the telomeres. This indicates that the reduc-
tion of TRF2 and other shelterin protein levels occurred prior to
the shortening of the telomeres in LMNA mutant cells. The deple-
tion in shelterin subunit protein levels in LMNA mutant primary
ﬁbroblasts was not corrected by introducing hTERT expression,
but it was partially restored in response to proteasome inhibitor
treatment. This supports our interpretation that the reduction
of TRF2 in LMNA mutant ﬁbroblasts is not merely secondary to
the shortening of telomeres, but is primarily caused by LMNA
mutations which lead to degradation of the TRF2 protein. In
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FIGURE 2 | Intranuclear localization ofTRF2 in primary fibroblasts.
(A) Abnormal nuclear morphology as measured via NCR andTRF2 expression
(green) in LMNA mutant cells. (B) Immuno-FISH staining of telomeres
(using a telomeric PNA probe; red), TRF2 (green) and DNA (using DAPI; blue)
in control, LMNA andWRN mutant cells. White boxes in the merged images
indicate areas that are enlarged 5× and shown to the bottom. Scale bar: 2 μm.
(C) Fractions of telomeric DNA co-localized to TRF2. Data were presented as
means ± s.d. Approximately 70 cells were analyzed for each cell line.
primary LMNA mutant cells, telomere damage and shortening
contribute to further reduction of TRF2. In LMNA mutant cell
cultures, the cells with more misshapen nuclei, as measured via
NCR, exhibited lower TRF2 protein levels. This also suggests a
causative role for mutant lamin A in the reduction of the TRF2
protein. In addition, LMNA mutant cells accumulated signiﬁcant
genomic DNA damage which persisted after ectopic expression of
hTERT.
Based on the above ﬁndings, we propose that LMNAmutations
ﬁrst induce the accumulation of double stranded DNA damage.
This damage then leads to the activation of the p53 pathway,
TRF2 degradation and telomere shortening (Figure 6). In this
scenario, double stranded DNA damage accumulates in LMNA
mutant cells in either telomeric or non-telomeric regions of the
DNA, which in turn causes TRF2 degradation. The disruption of
proper shelterin complex formation due to suboptimum levels of
TRF2 and other shelterin components may then destabilize the
telomeres, making them more vulnerable to nucleolytic degrada-
tion and accelerate telomere shortening and cellular senescence
(Sfeir and de Lange, 2012). Our results showing the presence of
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Table 2 | Correlation analysis of nuclear morphological abnormality
and reduction ofTRF2 within LMNA mutant primary fibroblast
cultures.
Cell Line PORTU8010 NORWAY1010
LMNA mutation R133L L140R
Nuclear contour ratio 0.749 ± 0.118 0.815 ± 0.074
Relative TRF2 intensity 54.6 ± 6.0 51.5 ± 5.3
Pearson’s correlation coefﬁcient (r ) 0.365 0.379
P value 0.003 0.01
Number of cells examined 65 40
Nuclear contour ratios (NCR) were calculated as 4πA/P2, where P = Perimeter,
A = Area. NCR value = 1, indicates a perfect circle.The correlation between NCR
and TRF2 protein amount in cells was determined using Pearson’s correlation
analysis. Pearson’s correlation coefﬁcient (r) is a number between −1 and 1. r
closer to 1 indicates a positive correlation, whereas r closer to −1 indicates a
negative correlation.
accumulated DNA damage in both LMNA mutant primary and
hTERTﬁbroblasts are consistent with such amodel (Figure 6, bold
arrows).
Considering the size of telomeric DNA relative to that of the
total genome, the number of double stranded DNA damage foci
per unit of DNA sequence may be higher in telomeric DNA than
in non-telomeric regions in primary LMNA mutant cells. How-
ever, there are substantially more DNA lesions in non-telomeric
DNA, consistent with a major and, perhaps, primary impact on
overall genomic instability. We speculate that the decrease in shel-
terin complex proteins might lead to the accumulation of damage
at telomeres at later passages of primary cultures correlated with
increased accumulation of mutant lamin A. TRF2 is also known
to have an essential role in non-telomeric DNA damage repair,
namely homologous recombination (Mao et al., 2007). It is there-
fore, possible, that depletion of TRF2 in LMNA mutant AWS
cells may contribute to compromised double strand break repair
and additional accumulation of DNA damage (Figure 6). The
expression levels of the shelterin subunits were also reduced in
WRN mutant ﬁbroblasts. This can be explained, in part, by the
accumulation of genomic DNA damage.
It is not known if the pattern or degree of DNA damage is
different depending on the type of LMNAmutation. The presence
of accumulated DNA damage in our LMNA mutant hTERT lines
is in agreement with a previous study of progerin expressing cells
by Scafﬁdi and Misteli (2006). In contrast, Benson et al. (2010),
described the accumulation of DNA damage almost exclusively
at the telomeres in HGPS cells, but not in hTERT HGPS cells.
Additional research is required to explain these discrepant results.
FIGURE 3 | Detection of γ-H2AX DNA damage foci in LMNA mutant cells.
(A) Immuno-FISH staining of telomeres (using a telomeric PNA probe; red),
γ-H2AX (green), and DNA (using DAPI; blue) in control, LMNA mutant and
WRN mutant cells. White boxes in the merged images indicate areas that are
enlarged 5× and shown to the bottom. Scale bar: 2 μm. (B) Percentages of
cells with >5 γ-H2AX-labeled foci. Data are averages of three independent
experiments. Bars represent ± s.d. *P < 0.05. (C) Quantitation of γ-H2AX
foci detected in (A). Signals of γ-H2AX foci overlapping telomeres (gray) and
those not overlapping (black) are shown separately. A minimum of 70 cells
were analyzed for each cell line. Scale bar: 2 μm.
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FIGURE 4 | Expression of shelterin subunits in hTERT-immortalized cell
lines of control, LMNA mutant andWRN mutant fibroblasts. (A)Western
analysis of TRF2, TRF1, POT1, TIN2, hRap1, andTPP1 in hTERT-immortalized
ﬁbroblasts of indicated cell lines. Autoradiographies with higher exposures
are shown for clariﬁcation of bands. (B) Analysis of relative telomere
lengths expressed as average telomere intensities ± s.d. in indicated cell
types, as shown in Figure 1. A minimum of 70 cells were analyzed for each
cell lines. Relative mean telomere lengths (±s.d.) were measured in
hTERT-immortalized ﬁbroblasts using qPCR. (C)TRF2 mRNA expression in
hTERT-immortalized normal, LMNA mutant andWRN mutant ﬁbroblasts.
TRF2 mRNA expression was detected by qRT-PCR. GAPDH mRNA was
used as an internal standard. Data are presented as mean ± s.d. from
three independent experiments. The control (82-6) value was taken as
onefold. (D) Expression of TRF2 protein after proteasome inhibition in
LMNA mutant cells. hTERT-immortalized cell lines of control and
LMNA mutant ﬁbroblasts were incubated in the presence or absence
of MG-132 for 6 h andTRF2 protein levels were detected using
immunoblotting.
The p53–Siah1–TRF2 pathwaywas recently demonstrated to be
amechanism of TRF2 degradation in senescent normal ﬁbroblasts
with short telomeres (Fujita et al., 2010). Studies of doxorubicin
treated colon cancer cells and lymphoblast cells provided evidence
that non-telomeric DNA damage can also activate the p53-Siah1
pathway and result in proteosomal degradation of TRF2 (Fujita
et al., 2010). Our observations of a preponderance of DNAdamage
in the non-telomeric genomicDNAof primary and LMNAmutant
hTERTcells raise thepossibility that this is the trigger leading to the
activation of the p53 pathway and the degradation of TRF2 protein
in LMNAmutant cells.We examined baseline phosphorylated p53
protein levels by western analysis (data not shown) which showed
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FIGURE 5 | Detection of γ-H2AX foci in control and LMNA mutant
fibroblasts expressing hTERT. (A) Percentage of cells with >5 γ-H2AX-
labeled foci, as stated in Figure 3. *P < 0.05, **P < 0.005, ***P < 0.001.
(B) Quantitation of γ-H2AX foci in indicated cell lines. Signals co-localizing
TRF2 (gray) and those not co-localizing (black) are separately shown. In each
condition approximately 70 cells were analyzed for each cell lines.
FIGURE 6 | Potential mechanisms ofTRF2 degradation and telomere
shortening in LMNA mutant AWS cells. Our data support the hypothesis
that in young passage cells, though mutant lamin may initiate some DNA
damage to the telomeres, the bulk of the DNA damage accumulates within
non-telomeric DNA (bold arrows). The latter may be largely responsible for
the initiation of a DNA damage response, followed byTRF2 degradation
and destabilization of the telomere–shelterin complex. These alterations in
turn cause rapid telomere attrition (Oh et al., 2003) and replicative
senescence in these cells. Depletion of TRF2 protein along with insufﬁcient
DNA damage repair may also increase the overall levels of genomic DNA
damage via a positive feedback loop (Mao et al., 2007). In senescent LMNA
mutant cells, all the pathways may be activated.
that variations among controls were larger than those between
controls and patient cell lines. Therefore we were unable to deter-
mine whether accumulation of non-telomeric DNA damage in
LMNAmutant cells involves the p53–Siah1 pathways.We observed
only a partial stabilization of TRF2 by the addition of proteosomal
degradation inhibitor, raising the possibility that other mecha-
nisms of protein degradationmay be contributing to the reduction
of TRF2 protein in LMNA mutant cells. For example, DNA dam-
age signaling cascades such as p53 and ATM induce autophagy
(Hasty et al., 2013). Autophagic activity measured by the LC3-II
levels was increased in skeletal muscles and other tissues derived
from the Zmpste24−/−, XPF−/−, and CSB/XPA−/− progeroid
mice (Marino et al., 2008). We recently observed increased basal
autophagy in LMNAmutant (R133L) ﬁbroblasts used in this study
(unpublished data).
We attempted to determine the TRF2 protein half-life
using a protein synthesis inhibitor, cycloheximide, in hTERT-
immortalized ﬁbroblasts. The previously reported TRF2 protein
half-life was longer than 12 h (Nijjar et al., 2005). Our results
also indicated that the half-life of TRF2 was greater than 12 h in
both control and LMNA mutant cells (data not shown). We were
therefore unable to determine the difference between the protein
half-life in LMNA mutant cells as compared to controls. It there-
fore remains a formal possibility that the reduction of TRF2 in
LMNA mutants, at least in part, may be due to a mechanism other
than protein instability, such as a decrease in translational efﬁcacy.
Although we have only studied the association of TRF2 with
telomeres, there is also a possibility that the binding of other
proteins involved in telomere replication or DNA repair factors
might be inhibited in LMNA mutant cells, thus contributing to
accelerated telomere shortening. The nuclear lamina has been
shown to function as a scaffold for chromatin (Broers et al.,
2006; Dechat et al., 2008) and various protein complexes (Zas-
trow et al., 2004) involved in the structural maintenance of the
nuclear membrane, gene regulation and signal transduction. In
LMNA mutant cells, the disruption of lamina-protein contain-
ing complexes and alterations of telomere chromatin structures
can affect the accessibility of telomere binding proteins, which
could lead to defects in telomere maintenance, including repair
and replication of telomeric DNA. Taken together, our data sug-
gest that the decreased level of the shelterin proteins is secondary
to the accumulation of DNA damage. The loss of protection of
the telomeres can therefore be considered one of the causative fac-
tors for the rapid telomere attrition observed in LMNA mutant
cells.
There is an increasing amount of evidence for DNA dam-
age and sustained genomic instability as the central cause for
laminopathies, including progeroid syndromes such as HGPS
(Liu et al., 2005; Scafﬁdi and Misteli, 2008; Benson et al., 2010;
Gonzalez-Suarez and Gonzalo, 2010). Complete loss of laminA or
mutant lamina may directly lead to genomic instability, including
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instability of the telomeres (Liu et al., 2005; Gonzalez-Suarez et al.,
2009). Telomere dysfunction then leads to genomic instability,
which triggers cellular senescence or apoptosis (Blackburn, 2001;
de Lange, 2005). Our study also supports this model, suggesting
that unrepaired DNA damage and therefore genomic instabil-
ity is the common mechanistic cause of the pathophysiology of
laminopathies.
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